SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin’s arm recalling 16,056 bottles of Rifampin Capsules in US market

21 Jan 2023 Evaluate

Lupin's US-based subsidiary -- Lupin Pharmaceuticals Inc is recalling 16,056 bottles of Rifampin Capsules, a medication used in the treatment of all forms of tuberculosis, in the US market due to a manufacturing issue. The company is recalling the affected lot due to Failed Impurities/ Degradation Specifications: Failure observed in related substance testing during long term stability study. The affected lot has been produced at Lupin's Aurangabad plant. The drug initiated Class II nationwide (US) recall of the affected lot on December 12 last year.

As per US Food and Drug Administration (USFDA), a class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.

Lupin Share Price

2442.35 43.65 (1.82%)
03-Jul-2026 09:55 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1904.30
Dr. Reddys Labs. 1369.10
Cipla 1463.50
Zydus Lifesciences 1112.40
Lupin 2442.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: